Top 89%
en este catálogo (1041 prácticas puntuadas)
Las puntuaciones se concentran en valores altos, por lo que la posición dentro del catálogo suele ser más reveladora que el número por sí solo.
Evidence of impact / measured public value1/3
Only descriptive pilot metrics are public (~110,000 people biometrically enrolled by March 2025 out of a 3.5 million target); no independent measurement of fraud reduction, cost savings or health-access gains has been published.
Transparency, fairness & accountability1/3
The fund's legal basis is public (Law n°19-2023) and its biometric launch was announced under the Prime Minister's patronage, but no audit of match accuracy, false-duplicate rates or data-protection safeguards has been released.
Transferability / demonstrated replication1/3
The ABIS was explicitly architected as multi-tenant so CAMU and CNSS share one deduplication engine, and the same vendor pattern (Innovatrics ABIS + Akieni integration) is documented as reusable across agencies, though replication beyond these two funds is not yet evidenced.
Scalability beyond pilot1/3
Enrolment has reached roughly 3% of CAMU's 3.5 million-person target after use, with coverage in only three cities (Brazzaville, Pointe-Noire, Oyo), so scale-up beyond the pilot is not yet demonstrated.
Governance, capability & sustainability1/3
A dedicated law and ministerial oversight underpin CAMU, and the biometric platform has a named systems integrator (Akieni/YAO Corp), but no independent regulator or public audit of the AI-driven deduplication process is documented.
Evidoria. El ABIS biométrico multiinquilino de la CAMU/CNSS — la República del Congo elimina duplicados en la afiliación al seguro de salud universal. ID persistente: da4c3c94-8e06-4a1e-a597-6aff2ea2f908.